Troncone R, Ferguson A
Gastro-Intestinal Unit, Western General Hospital, Edinburgh, UK.
Clin Exp Immunol. 1988 May;72(2):284-7.
When an antigen is first presented via the gut, either priming or suppression of the systemic immune response may result. Many factors influence the outcome, including physico-chemical properties of the antigen. The aim of this study is to establish if wheat gliadin behaves as an oral immunogen or tolerogen. Mice reared on a gluten-free diet were fed gliadin, either as wheat flour in a standard rodent diet or as the purified molecule. Immune status (tolerant or sensitized) was then defined by measuring specific systemic immune responses after parenteral immunization of gliadin-fed and control mice. A single feed of 25 or 125 mg of purified gliadin resulted in a dose-dependent suppression of both cell-mediated and humoral immune responses. Similar oral tolerance was achieved by feeding mice with a gluten-containing diet for a week. Finally, mice reared on a normal, gluten-containing diet showed evidence of established oral tolerance, with significantly lower systemic immune response to gliadin than mice reared on gluten-free diet. These results indicate that gliadin is an effective oral tolerogen. In vivo studies on the immunogenicity of gliadins should be conducted in animals from gluten-free colonies.
当抗原首次通过肠道呈递时,可能会引发全身免疫反应的启动或抑制。许多因素会影响结果,包括抗原的物理化学性质。本研究的目的是确定小麦醇溶蛋白是作为口服免疫原还是耐受原。以无麸质饮食饲养的小鼠喂食醇溶蛋白,其形式可以是标准啮齿动物饮食中的小麦粉,也可以是纯化分子。然后,通过测量喂食醇溶蛋白的小鼠和对照小鼠经肠胃外免疫后的特异性全身免疫反应来确定免疫状态(耐受或致敏)。单次喂食25毫克或125毫克纯化醇溶蛋白会导致细胞介导的免疫反应和体液免疫反应均出现剂量依赖性抑制。通过给小鼠喂食含麸质饮食一周也能实现类似的口服耐受。最后,以正常含麸质饮食饲养的小鼠显示出已建立口服耐受的证据,与以无麸质饮食饲养的小鼠相比,其对醇溶蛋白的全身免疫反应明显更低。这些结果表明醇溶蛋白是一种有效的口服耐受原。关于醇溶蛋白免疫原性的体内研究应在来自无麸质群体的动物中进行。